Why it's different
Three reasons these programs stall.
Platform policy blocks the obvious ads
Prescription-medication language, before-and-after imagery, and outcome claims get rejected. Clinics either water everything down or keep resubmitting the same campaign.
Patients arrive skeptical
They have read conflicting things about compounded versus brand, side effects, and cost. Without education, interest never becomes a consultation request.
Every competitor looks identical
Same offer, same stock photo, same price anchor. Without provider credibility and a real point of view, the decision defaults to whoever is cheapest.
What we build
The GLP‑1 and peptide growth stack.
Next step
Find out why your program isn't converting.
Thirty minutes on your visibility, consult path, and follow-up — with a written summary of the gaps we find.